Dr. Arifa Akram

Dr. Dr. Arifa Akram


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2018 in VirusDisease
Verified
Journal Article
Closed access
PDF file
AMA. K. M. Muraduzzaman
A. K. M. Muraduzzaman
AAAhmed Nawsher Alam
Ahmed Nawsher Alam
SSSharmin Sultana
Sharmin Sultana
MSMahmuda Siddiqua
Mahmuda Siddiqua
MKManjur Hossain Khan
Manjur Hossain Khan
TSTahmina Shirin
Tahmina Shirin

1 May 2019 in New Microbes and New Infections
Verified
Journal Article
Open access
TSTahmina Shirin
Tahmina Shirin
AMA.K.M. Muraduzzaman
A.K.M. Muraduzzaman
AAA.N. Alam
A.N. Alam
SSS. Sultana
S. Sultana
MSM. Siddiqua
M. Siddiqua
MFM.S. Flora
M.S. Flora

17 August 2019 in Bangladesh Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
DADr. Arifa Akram
Dr. Arifa Akram
Not Available Bangladesh Journal of Infectious Diseases, June 2019;6(1):1-2

16 May 2018 in Journal of Viral Hepatitis
Verified
Journal Article
Closed access
PDF file
DADr. Arifa Akram
Dr. Arifa Akram
SIS M Rashedul Islam
S M Rashedul Islam
SMSaif Ullah Munshi
Saif Ullah Munshi
STShahina Tabassum
Shahina Tabassum

21 January 2020 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
RPRepon C Paul
Repon C Paul
ANArifa Nazneen
Arifa Nazneen
KBKajal C Banik
Kajal C Banik
Shariful Amin Amin SumonShariful Amin Amin Sumon
Shariful Amin Amin Sumon
KPKishor K Paul
Kishor K Paul
EGEmily S Gurley
Emily S Gurley
In the absence of reliable data on the burden of hepatitis E virus (HEV) in high endemic countries, we established a hospital-based acute jaundice surveillance program in six tertiary hospitals in Bangladesh to estimate the burden of HEV infection among hospitalized acute jaundice patients aged ≥14 years, identify seasonal and geographic patterns in the prevalence of hepatitis E, and examine factors associated with death. We collected blood specimens from enrolled acute jaundice patients, defined as new onset of either yellow eyes or skin during the past three months of hospital admission, and tested for immunoglobulin M (IgM) antibodies against HEV, HBV and HAV. The enrolled patients were followed up three months after hospital discharge to assess their survival status; pregnant women were followed up three months after their delivery to assess pregnancy outcomes. From December’2014 to September’2017, 1925 patients with acute jaundice were enrolled; 661 (34%) had acute hepatitis E, 48 (8%) had hepatitis A, and 293 (15%) had acute hepatitis B infection. Case fatality among hepatitis E patients was 5% (28/589). Most of the hepatitis E cases were males (74%; 486/661), but case fatality was higher among females—12% (8/68) among pregnant and 8% (7/91) among non-pregnant women. Half of the patients who died with acute hepatitis E had co-infection with HAV or HBV. Of the 62 HEV infected mothers who were alive until the delivery, 9 (15%) had miscarriage/stillbirth, and of those children who were born alive, 19% (10/53) died, all within one week of birth. This study confirms that hepatitis E is the leading cause of acute jaundice, leads to hospitalizations in all regions in Bangladesh, occurs throughout the year, and is associated with considerable morbidity and mortality. Effective control measures should be taken to reduce the risk of HEV infections including improvements in water quality, sanitation and hygiene practices and the introduction of HEV vaccine to high-risk groups. In the absence of reliable surveillance data on the burden of hepatitis E in endemic countries, we conducted a hospital-based acute jaundice surveillance study over a two and a half year period in six tertiary hospitals in Bangladesh. The study confirms that HEV infections occur throughout the year, and is a major (34%) cause of acute jaundice in tertiary hospitals in Bangladesh. Three-quarters of the acute hepatitis E cases were male, and HEV infection was higher among patients residing in urban areas than patients in rural areas (41% vs 32%). The overall case fatality rate of acute HEV infections in hospitals was 5%, but was higher among pregnant women (12%). Hepatitis E patients who died were more likely to have co-infection with HAV or HBV than the HEV infected patients who did not die. Fifteen percent of HEV infected mothers had miscarriage/stillbirth. Of the children who were born alive, 19% died, all within one week of birth. Considering the high burden of hepatitis E among hospitalized acute jaundice patients, Bangladesh could take control measures to reduce this risk including improvements in water quality, sanitation and hygiene practices and the introduction of hepatitis E vaccine in high-risk areas.

16 January 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AMA K M Muraduzzaman
A K M Muraduzzaman
MKManjur Hossain Khan
Manjur Hossain Khan
RPRezina Parveen
Rezina Parveen
SSSharmin Sultana
Sharmin Sultana
AAAhmed Nawsher Alam
Ahmed Nawsher Alam
TSTahmina Shirin
Tahmina Shirin
Every year around 150,000 pilgrims from Bangladesh perform Umrah and Hajj. Emergence and continuous reporting of MERS-CoV infection in Saudi Arabia emphasize the need for surveillance of MERS-CoV in returning pilgrims or travelers from the Middle East and capacity building of health care providers for disease containment. The Institute of Epidemiology, Disease Control & Research (IEDCR) under the Bangladesh Ministry of Health and Family welfare (MoHFW), is responsible for MERS-CoV screening of pilgrims/ travelers returning from the Middle East with respiratory illness as part of its outbreak investigation and surveillance activities. Bangladeshi travelers/pilgrims who returned from the Middle East and presented with fever and respiratory symptoms were studied over the period from October 2013 to June 2016. Patients with respiratory symptoms that fulfilled the WHO MERS-CoV case algorithm were tested for MERS-CoV and other respiratory tract viruses. Beside surveillance, case recognition training was conducted at multiple levels of health care facilities across the country in support of early detection and containment of the disease. Eighty one suspected cases tested by real time PCR resulted in zero detection of MERS-CoV infection. Viral etiology detected in 29.6% of the cases was predominantly influenza A (H1N1 and H3N2), and influenza B infection (22%). Peak testing occurred mostly following the annual Hajj season. Respiratory tract infections in travelers/pilgrims returning to Bangladesh from the Middle East are mainly due to influenza A and influenza B. Though MERS-CoV was not detected in the 81 patients tested, continuous screening and surveillance are essential for early detection of MERS-CoV infection and other respiratory pathogens to prevent transmissions in hospital settings and within communities. Awareness building among healthcare providers will help identify suspected cases.